Martin Shkreli’s Latest Plan to Sharply Raise Drug Price Prompts Outcry
Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients’ reach.
